European Association for the Study of Diabetes Sep 17 2025 GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics . GLP-1 drugs such as semaglutide are widely used to treat type 2 diabetes and obesity. They do this by

Tag-uri: Austria